Resources

Publication: Scalable generation of functional human iPSC-derived CAR-macrophages that efficiently eradicate CD19-positive leukemia

In this study, CERO bioreactor was used for continuous upscaled production of CAR-iMacs. The formation of the hemanoids was highlighted, which were continuously shedding the CAR-iMacs. Quantities of CAR-iMacs were harvested from the supernatants at different weeks from the ongoing bioreactor differentiation using CERO. The paper provides results from generating CAR-macrophages from various stem cell sources using modern upscaling technologies for next-generation immune cell farming. The generated cells exhibited increased functionality in the form of enhanced and antigen-dependent phagocytosis of CD19+ target cancer cells along with increased pro-inflammatory responses.

Related Resources

In this study, CellRaft AIR was used to isolate, verify, and expand monoclonal cell lines carrying engineered SF3B1 mutations, forming the basis of an isogenic...

In this work, CellRaft arrays were used to generate clonally derived cell populations from single cells prior to sequencing, providing a ground-truth reference for benchmarking...

In this study, CellRaft AIR was used to isolate and track single hematopoietic stem and progenitor cell (HSPC) clones over time, enabling researchers to directly...